(Q48257561)

10 February 2018

title

Glomerular hyperfiltration: definitions, mechanisms and clinical implications. (English)

1 reference

10 February 2018

author

Robert William Schrier

4

object named as

Robert W Schrier

1 reference

10 February 2018

author name string

Imed Helal

1

1 reference

10 February 2018

Godela M Fick-Brosnahan

2

1 reference

10 February 2018

Berenice Reed-Gitomer

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

21 February 2012

1 reference

10 February 2018

Nature Reviews Nephrology

published in

1 reference

10 February 2018

volume

8

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

293-300

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.19

exact match

0 references

cites work

Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renal functional reserve in obesity hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Short-term protein loading in assessment of patients with renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The hyperfiltration theory: a paradigm shift in nephrology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hemodynamics in experimental diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Hemodynamic theory of progressive renal disease: a 10-year update in brief review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Hyperfiltration evaluated by glomerular filtration rate at diagnosis in children with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Hyperfiltration affects accuracy of creatinine eGFR measurement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Dilemmas in human and rat pregnancy: proposed mechanisms relating to arterial vasodilation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Role of relaxin in maternal renal vasodilation of pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Mechanisms of renal vasodilation and hyperfiltration during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Mechanisms of diabetic hyperfiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Effects of insulin-like growth factor I on renal function in normal men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Current concepts of renal hemodynamics in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Early glycosylation products induce glomerular hyperfiltration in normal rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Dietary sodium intake in a sample of adult male population in southern Italy: results of the Olivetti Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Rate of functional deterioration in polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Early renal abnormalities in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

MYO1E, focal segmental glomerulosclerosis, and the cytoskeleton

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Podocyte lesions in patients with obesity-related glomerulopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renal dysfunction in patients with thalassaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Early glomerular dysfunction in patients with sickle cell anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

High altitude renal syndrome (HARS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Mechanisms of development and progression of cyanotic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Combined renal effects of overweight and hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Obesity, Glomerular Hyperfiltration, and the Surface Area Correction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Early histological changes in the kidney of people with morbid obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration: a new marker of metabolic risk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Proteinuria in obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The role of renin angiotensin system inhibition in kidney repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Limitations of angiotensin inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.19

Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease

31 March 2020

1 reference

12 December 2020

Glomerular hypertension: cause and consequence of renal injury

1 reference

12 December 2020

Assessing kidney function--measured and estimated glomerular filtration rate

1 reference

12 December 2020

The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease

1 reference

12 December 2020

Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption

1 reference

12 December 2020

The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy

1 reference

12 December 2020

Nephron adaptation to renal injury or ablation

1 reference

12 December 2020

Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.

1 reference

12 December 2020

Renal findings in patients with short-term type 2 diabetes.

1 reference

12 December 2020

Functional and structural changes in the kidney in the early stages of obesity

1 reference

12 December 2020

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

1 reference

12 December 2020

Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy

1 reference

12 December 2020

The role of intraglomerular pressure in the initiation and progression of renal disease

1 reference

12 December 2020

The renal hemodynamic basis of diabetic nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.19

1 reference

10 February 2018

1 reference

10 February 2018